May 18, 2020 / 11:24 AM / 11 days ago

BRIEF-Vbl Therapeutics To Present New Data On Its MOSPD2 Bispecific Antibody Program For Solid Tumors

May 18 (Reuters) - Vascular Biogenics Ltd:

* VBL THERAPEUTICS TO PRESENT NEW DATA ON ITS MOSPD2 BISPECIFIC ANTIBODY PROGRAM FOR SOLID TUMORS IN LATE BREAKING RESEARCH SESSION OF THE AACR VIRTUAL ANNUAL MEETING Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below